Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Vanessa Innao
Observed names:
Innao V,
V Innao,
V. Innao,
VANESSA INNAO
Institution:
Ospedale Garibaldi
Observed institutions:
University of Messina,
National Institutes of Health,
Howard Hughes Medical Institute,
Ospedale Garibaldi,
Fondazione Gimema Onlus,
Azienda Ospedaliera Universitaria Policlinico "G. Martino",
Ospedale Policlinico San Martino,
Wellcome Trust,
University of Bologna
show all 9
ORCID:
0000-0001-7596-1912
Observed ORCID:
0000-0001-7596-1912
OpenAlex ID:
A5013254549
Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies
2016
·
Alessandro Allegra
, Vanessa Innao
, et al.
·
Cancer Investigation
·
238
Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma
2017
·
Caterina Musolino
, Alessandro Allegra
, et al.
·
Mediators of Inflammation
·
168
PDF
The Cancer Stem Cell Hypothesis: A Guide to Potential Molecular Targets
2014
·
Alessandro Allegra
, Andrea Alonci
, et al.
·
Cancer Investigation
·
103
Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma
2017
·
Roberta Ettari
, Maria Zappalà
, et al.
·
Pharmacology & Therapeutics
·
86
New orally active proteasome inhibitors in multiple myeloma
2013
·
Alessandro Allegra
, Andrea Alonci
, et al.
·
Leukemia Research
·
74
Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies
2020
·
Alessandro Allegra
, Alessandro Allegra
, et al.
·
Annals of Hematology
·
67
PDF
Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw
2018
·
Caterina Musolino
, Giacomo Oteri
, et al.
·
Annals of Hematology
·
55
Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma
2013
·
Alessandro Allegra
, Giuseppa Penna
, et al.
·
European Journal Of Haematology
·
49
PDF
Reduced IL ‐33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease
2012
·
Caterina Musolino
, Alessandro Allegra
, et al.
·
British Journal of Haematology
·
49
PDF
Formaldehyde Exposure and Acute Myeloid Leukemia: A Review of the Literature
2019
·
Alessandro Allegra
, Giovanna Spatari
, et al.
·
Medicina
·
42
PDF
Adoptive immunotherapy for hematological malignancies: Current status and new insights in chimeric antigen receptor T cells
2016
·
Alessandro Allegra
, Vanessa Innao
, et al.
·
Blood Cells Molecules and Diseases
·
39
Nanobodies and Cancer: Current Status and New Perspectives
2018
·
Alessandro Allegra
, Alessandro Allegra
, et al.
·
Cancer Investigation
·
34
The metabolomic signature of hematologic malignancies
2016
·
Alessandro Allegra
, Vanessa Innao
, et al.
·
Leukemia Research
·
33
Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
2019
·
Alessandro Allegra
, Vanessa Innao
, et al.
·
International Journal of Molecular Sciences
·
32
PDF
Therapeutic potential of antagomiRs in haematological and oncological neoplasms
2020
·
Vanessa Innao
, Alessandro Allegra
, et al.
·
European Journal of Cancer Care
·
31
PDF
Immune checkpoint inhibitors in multiple myeloma: A review of the literature
2020
·
Santino Caserta
, Vanessa Innao
, et al.
·
Pathology - Research and Practice
·
30
Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network
2019
·
Concetta Conticello
, Alessandra Romano
, et al.
·
Journal of Clinical Medicine
·
27
PDF
Telomerase and telomere biology in hematological diseases: A new therapeutic target
2017
·
Alessandro Allegra
, Alessandro Allegra
, et al.
·
Leukemia Research
·
26
Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trials
2019
·
Massimo Martino
, Marco Rossi
, et al.
·
Expert Review of Hematology
·
25
Antiresorptive Agents and Anti-Angiogenesis Drugs in the Development of Osteonecrosis of the Jaw
2019
·
Alessandro Allegra
, Vanessa Innao
, et al.
·
The Tohoku Journal of Experimental Medicine
·
25
PDF
Promising Anti-Mitochondrial Agents for Overcoming Acquired Drug Resistance in Multiple Myeloma
2021
·
Vanessa Innao
, Vincenzo Rizzo
, et al.
·
Cells
·
24
PDF
New Frontiers about the Role of Human Microbiota in Immunotherapy: The Immune Checkpoint Inhibitors and CAR T-Cell Therapy Era
2020
·
Vanessa Innao
, Andrea Gaetano Allegra
, et al.
·
International Journal of Molecular Sciences
·
24
PDF
Myeloma cells induce the accumulation of activated CD94low NK cells by cell-to-cell contacts involving CD56 molecules
2020
·
Chiara Barberi
, Claudia De Pasquale
, et al.
·
Blood Advances
·
23
PDF
Post-chemotherapy cognitive impairment in hematological patients: current understanding of chemobrain in hematology
2020
·
Alessandro Allegra
, Alessandro Allegra
, et al.
·
Expert Review of Hematology
·
23
Role of the microbiota in hematologic malignancies.
2019
·
A Allegra
, V Innao
, et al.
·
PubMed
·
23
Show more works
View as search
Works count:
114
Citation count:
1,898
H-index:
23
I10-index:
50
Year
Topic
Type
